Lecture 8b Business Development in Pharmaceuticals

Why BD exists

complex processes, collaboration, risk management, connecting access and innovation

Upfront payments

Upfront payments are one -time payments made when the deal is signed, providing immediate value and early funding.

Milestone payments

Milestone payments are conditional and triggered by achievement of specific development or regulatory goals

Royalties

Royalties are ongoing payments based on a percentage of future product sales, sharing long -term success.

Licensing deals

rights to develop and sell drugs while retaining IP ownership

co-development partnerships

Collaborative agreements between companies to jointly develop a drug, sharing costs and risks while pooling expertise.

acquisition deals

Acquisition deals involve one company purchasing another to gain access to its products, technology, or market share, often to enhance portfolio and growth opportunities.